Swedbank’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.8M | Sell |
470,253
-95,157
| -17% | -$7.44M | 0.04% | 260 |
|
|
2025
Q1 | $41M | Sell |
565,410
-215,076
| -28% | -$15.6M | 0.05% | 225 |
|
|
2024
Q4 | $57.8M | Sell |
780,486
-189,026
| -19% | -$14M | 0.07% | 189 |
|
|
2024
Q3 | $64M | Sell |
969,512
-259,245
| -21% | -$17.1M | 0.08% | 181 |
|
|
2024
Q2 | $114M | Buy |
+1,228,757
| New | +$114M | 0.15% | 115 |
|
|
2024
Q1 | – | Sell |
-1,493,978
| Closed | -$114M | – | 625 |
|
|
2023
Q4 | $114M | Sell |
1,493,978
-25,246
| -2% | -$1.93M | 0.18% | 99 |
|
|
2023
Q3 | $105M | Sell |
1,519,224
-157,467
| -9% | -$10.9M | 0.18% | 102 |
|
|
2023
Q2 | $158M | Buy |
1,676,691
+136,714
| +9% | +$12.9M | 0.27% | 72 |
|
|
2023
Q1 | $127M | Sell |
1,539,977
-71,397
| -4% | -$5.91M | 0.25% | 85 |
|
|
2022
Q4 | $120M | Sell |
1,611,374
-2,232
| -0.1% | -$167K | 0.26% | 85 |
|
|
2022
Q3 | $133M | Buy |
1,613,606
+101,340
| +7% | +$8.37M | 0.32% | 64 |
|
|
2022
Q2 | $144M | Sell |
1,512,266
-44,126
| -3% | -$4.2M | 0.32% | 65 |
|
|
2022
Q1 | $183M | Sell |
1,556,392
-14,199
| -0.9% | -$1.67M | 0.34% | 64 |
|
|
2021
Q4 | $205M | Buy |
1,570,591
+3,819
| +0.2% | +$499K | 0.34% | 54 |
|
|
2021
Q3 | $177M | Sell |
1,566,772
-1,015
| -0.1% | -$115K | 0.33% | 56 |
|
|
2021
Q2 | $162M | Buy |
1,567,787
+14,944
| +1% | +$1.55M | 0.3% | 65 |
|
|
2021
Q1 | $130M | Buy |
1,552,843
+37,761
| +2% | +$3.16M | 0.27% | 80 |
|
|
2020
Q4 | $136M | Buy |
1,515,082
+163,441
| +12% | +$14.7M | 0.4% | 74 |
|
|
2020
Q3 | $108M | Sell |
1,351,641
-212,957
| -14% | -$17M | 0.37% | 79 |
|
|
2020
Q2 | $108M | Buy |
+1,564,598
| New | +$108M | 0.39% | 78 |
|